Narayana Hrudayalaya

1,758.90
+34.60
(2.01%)
ann
There are 2 new updates from the company18 hours ago
Viewcross
right
Market Cap
35,945.02 Cr
EPS
38.86
PE Ratio
44.21
Dividend Yield
0.26 %
52 Week High
1,871.60
52 Week Low
1,080.00
PB Ratio
9.71
Debt to Equity
0.50
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from8 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell+25.00 %
+25.00 %

Company News

View All News
Caret
positive
Narayana Hrudayalaya Reports Q4 Results and Dividend5 days ago
Narayana Hrudayalaya has announced its quarterly results and dividend. The company's Q4 EBITDA increased to 3.85 billion rupees from 3.14 billion rupees year-over-year. The EBITDA margin improved to 26.07% from 25.26% in the same period. Additionally, the company has recommended a dividend of 4.5 rupees per equity share.
positive
Narayana Hrudayalaya Reports Q4 Financial Results5 days ago
Narayana Hrudayalaya announced its Q4 consolidated net profit of 1.97 billion rupees, compared to 1.91 billion rupees year-over-year and 1.92 billion rupees quarter-over-quarter. The company's Q4 revenue increased to 14.7 billion rupees from 12.8 billion rupees in the same quarter last year.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,139.60
#1 1,10,785.31
98.86
5,584.10
18.77
#1 1,058
26.84
51.53
6,933.00
99,685.90
76.28
#1 19,165.50
14.74
917
49.14
50.68
715.10
53,987.06
63.40
6,931.20
8.99
645
-7.43
58.47
1,758.90
#4 35,945.02
#2 44.21
#4 5,093.40
#8 10.96
#3 790
#7 3.41
45.69
1,197.40
32,160.65
62.62
2,759.20
#1 25.09
326
-20.35
49.96
540.90
27,018.66
73.01
3,723.70
22.85
205
#1 3,986.36
52.05
650.00
26,009.03
69.19
2,511.20
12.94
336
48.39
51.21
5,890.00
14,925.87
#1 31.63
599.90
11.69
58
4.79
57.85
1,398.00
14,196.92
58.71
1,334.00
10.76
218
10.57
57.52
1,443.00
9,461.18
49.01
1,095.50
21.32
177
-0.88
49.82
Forecast
Actual
Growth Rate
Revenue Growth
10.96 %
Net Income Growth
30.17 %
Cash Flow Change
-1.66 %
ROE
-3.76 %
ROCE
-15.58 %
EBITDA Margin (Avg.)
7.25 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
365
378
409
400
432
455
492
459
489
526
565
558
653
655
714
735
776
782
829
791
750
398
611
755
846
867
952
967
951
1,041
1,173
1,140
1,236
1,249
1,324
1,222
1,273
1,364
1,424
1,353
1,503
Expenses
326
344
360
358
392
402
426
406
425
473
502
502
597
607
640
657
676
675
702
684
659
486
575
648
698
728
774
787
768
842
898
874
946
963
997
925
955
1,037
1,092
1,028
1,126
EBITDA
39
34
49
42
40
54
66
53
64
53
63
56
56
49
74
79
101
107
127
107
92
-87
36
107
148
139
179
180
182
200
275
266
290
286
327
297
318
327
332
325
377
Operating Profit %
10 %
8 %
11 %
10 %
8 %
11 %
13 %
11 %
12 %
9 %
10 %
9 %
8 %
7 %
10 %
10 %
12 %
13 %
15 %
13 %
11 %
-23 %
4 %
14 %
17 %
15 %
18 %
18 %
18 %
19 %
21 %
23 %
23 %
22 %
24 %
23 %
23 %
23 %
22 %
23 %
24 %
Depreciation
19
18
18
19
21
19
20
20
21
22
29
24
26
33
34
35
36
41
43
46
55
46
46
47
45
45
46
46
47
48
49
57
56
59
55
63
65
62
65
70
83
Interest
12
9
8
6
6
6
5
6
6
10
8
8
21
17
18
18
18
22
22
21
21
20
19
19
18
17
17
16
16
15
15
19
21
21
23
25
28
34
35
37
41
Profit Before Tax
10
10
26
20
13
29
41
28
37
21
26
24
9
-1
22
26
47
43
62
40
16
-153
-30
42
85
77
116
117
119
137
211
190
214
206
248
209
225
232
232
219
254
Tax
11
11
16
14
8
12
15
11
15
10
10
10
-1
3
8
13
10
13
17
9
4
-34
-26
1
17
1
17
20
50
27
42
36
40
22
22
21
34
30
33
26
57
Net Profit
-1
-1
10
6
5
17
27
17
22
11
17
14
10
-4
14
13
37
30
45
31
12
-120
-3
41
68
76
99
98
69
111
169
154
173
184
227
188
191
202
199
193
197
EPS in ₹
0.00
-0.03
0.52
0.29
0.25
0.85
1.31
0.84
1.10
0.54
0.82
0.70
0.48
-0.21
0.67
0.63
1.83
1.49
2.23
1.55
0.59
-5.90
-0.17
2.01
3.35
3.75
4.89
4.80
3.40
5.45
8.31
7.57
8.53
9.06
11.16
9.26
9.39
9.92
9.78
9.50
9.71

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Fixed Assets
913
1,055
1,082
1,848
1,838
2,092
1,961
1,980
2,336
2,651
Current Assets
260
286
302
479
527
586
665
909
1,294
1,946
Capital Work in Progress
20
14
53
35
56
12
20
67
259
514
Investments
0
87
96
9
17
86
120
132
252
844
Other Assets
437
401
416
644
725
701
669
951
1,315
1,615
Total Liabilities
1,370
1,556
1,647
2,536
2,637
2,891
2,770
3,131
4,162
5,625
Current Liabilities
343
315
323
510
510
602
703
780
987
1,110
Non Current Liabilities
258
365
361
989
1,045
1,153
946
861
1,042
1,629
Total Equity
769
876
963
1,036
1,082
1,137
1,121
1,489
2,132
2,885
Reserve & Surplus
568
674
761
833
878
933
917
1,286
1,928
2,681
Share Capital
200
204
204
204
204
204
204
204
204
204

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-6
42
28
-22
89
8
-2
59
-4
97
Investing Activities
-223
-150
-146
-520
-162
-189
-113
-267
-1,176
-1,458
Operating Activities
77
174
219
182
279
443
304
485
1,085
1,067
Financing Activities
140
18
-45
315
-27
-247
-194
-159
88
489

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
63.85 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
11.60 %
0.00 %
10.91 %
10.01 %
9.68 %
9.44 %
9.66 %
DIIs
14.80 %
15.55 %
16.15 %
14.61 %
13.76 %
13.43 %
16.18 %
14.58 %
14.14 %
11.95 %
10.89 %
9.46 %
9.51 %
8.23 %
7.90 %
8.69 %
8.52 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.00 %
0.00 %
0.00 %
Public / Retail
4.64 %
4.97 %
4.85 %
5.11 %
5.92 %
6.87 %
5.86 %
6.93 %
7.10 %
7.99 %
8.46 %
9.04 %
10.00 %
11.68 %
12.13 %
11.58 %
11.47 %
Others
16.71 %
15.63 %
15.14 %
16.43 %
16.46 %
15.85 %
14.11 %
14.64 %
14.90 %
16.20 %
5.20 %
17.65 %
5.73 %
6.23 %
6.43 %
6.43 %
6.50 %
No of Share Holders
0
36,360
44,526
43,565
43,807
52,747
65,173
68,130
75,370
86,631
1,02,994
1,20,506
1,38,052
1,60,686
1,78,356
1,77,792
1,85,787

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 1 1 0.00 1 2.5 4 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.4 0.25 0.00 0.13 0.19 0.24 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Aug 2025 1,724.30 1,722.85
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 1,790.70 1,724.30
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 1,372.70 1,329.00
31 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Oct 2024 1,236.20 1,222.55
30 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Aug 2024 1,255.10 1,265.50
02 Aug 2024 DIVIDEND Dividend
₹ 4.00 /share
02 Aug 2024 1,255.10 1,252.75
07 Jul 2023 DIVIDEND Dividend
₹ 2.50 /share
07 Jul 2023 767.85 1,012.95
23 Aug 2022 DIVIDEND Dividend
₹ 1.00 /share
22 Aug 2022 659.80 705.15

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance18 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation18 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Clarification To The Volume Movement Letter Dated May 27 2025 Received From BSE Ltd.2 days ago
Clarification sought from Narayana Hrudayalaya Ltd2 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.5 days ago
General Updates - Amended Code Of Conduct For Prohibition Of Insider Trading.5 days ago
Shareholders Meeting5 days ago
Announcement under Regulation 30 (LODR)-Change in Management5 days ago
General Updates - Recommendation By The Board For The Issuance Of Non-Convertible Securities.5 days ago
Record Date - For Dividend5 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Corporate Action-Board approves Dividend5 days ago
Board Meeting Outcome for Outcome Of The Board Meeting For The Financial Results For The Quarter And Year Ended March 3120255 days ago
Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 20255 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation10 days ago
Board Meeting Intimation for Approval Of The Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Year Ended March 31 2025 Dividend And Fund RaisingMay 16, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015-RevisedApr 30, 2025
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 14, 2025
Rumour verification - Regulation 30(11)Apr 08, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsApr 05, 2025
Intimation Regarding Agreement Between The Wholly Owned Subsidiary Of The Company- Narayana Vaishno Devi Specialty Hospitals Private Limited With Shri Mata Vaishnodevi Charitable SocietyMar 28, 2025
Closure of Trading WindowMar 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2025
Regulation 30_Intimation Regarding The Execution Of Joint Venture Agreement By Health City Cayman Islands A Wholly Owned Subsidiary Of The Company.Mar 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 24, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2025
Intimation Under Regulation 30 Read With Para B Of Part A Of Schedule III Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 20, 2025
Rumour verification - Regulation 30(11)Feb 18, 2025
Announcement under Regulation 30 (LODR)-AllotmentFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Intimation Of Acquisition Of Shares By A Wholly-Owned Overseas Subsidiary Of The CompanyFeb 14, 2025
Integrated Filing (Financial)Feb 14, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 14, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On February 14 2025Feb 14, 2025
Result_Unaudited Financial Result For The Quarter And Nine Month Ended December 31 2024Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Board Meeting Intimation for To Consider And Approve The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended December 31 2024Feb 07, 2025
Intimation Regarding Purchase Of Land At BengaluruFeb 05, 2025

Technical Indicators

RSI(14)
Neutral
45.69
ATR(14)
Less Volatile
59.85
STOCH(9,6)
Neutral
22.71
STOCH RSI(14)
Neutral
31.07
MACD(12,26)
Bearish
-9.42
ADX(14)
Weak Trend
15.30
UO(9)
Bearish
33.32
ROC(12)
Downtrend And Accelerating
-3.18
WillR(14)
Oversold
-86.72

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Samco Active Momentum Fund Direct - Growth
104782
2.14%
2.14%
2.14%
Apr 2025
Navi Nifty Smallcap250 Momentum Quality 100 Index Fund Direct - Growth
0
0.00%
-2.05%
0.00%
Apr 2025
Samco Special Opportunities Fund Direct - Growth
23214
2.73%
0.63%
2.73%
Apr 2025
Taurus Ethical Fund Direct-Growth
64759
3.99%
0.59%
0.82%
Apr 2025
DSP Multicap Fund Direct - Growth
82299
0.70%
-0.55%
-0.66%
Apr 2025
DSP Small Cap Direct Plan-Growth
1005565
1.24%
-0.35%
-0.50%
Apr 2025
Shriram Multi Asset Allocation Fund Direct - Growth
0
0.00%
-0.34%
-0.30%
Apr 2025
DSP Focus Direct Plan-Growth
199536
1.42%
-0.33%
-1.80%
Apr 2025
DSP Healthcare Fund Direct - Growth
248442
1.50%
-0.30%
-0.07%
Apr 2025
Mirae Asset Multicap Fund Direct - Growth
140712
0.71%
-0.18%
-0.23%
Apr 2025
Navi Nifty 500 Multicap 50:25:25 Index Fund Direct-Growth
0
0.00%
-0.17%
-0.14%
Apr 2025
Sundaram Business Cycle Fund Direct - Growth
160489
1.68%
-0.12%
-0.40%
Apr 2025
Mirae Asset Small Cap Fund Direct-Growth
149851
1.90%
-0.10%
-0.15%
Apr 2025
Motilal Oswal Nifty MidSmall Healthcare Index Fund Direct-Growth
2994
2.18%
0.10%
0.19%
Apr 2025
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth
16649
2.18%
0.09%
0.18%
Apr 2025
Shriram ELSS Tax Saver Fund Direct - Growth
5800
2.12%
0.07%
2.12%
Apr 2025
Shriram Multi Sector Rotation Fund Direct-Growth
45305
4.10%
0.07%
2.04%
Apr 2025
Shriram Flexi Cap Fund Direct - Growth
15800
2.08%
0.06%
2.08%
Apr 2025
Quantum Ethical Fund Direct - Growth
3225
1.11%
-0.06%
-0.05%
Apr 2025
Nippon India Pharma Fund Direct-Growth
1426170
3.04%
0.05%
0.20%
Apr 2025
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct - Growth
8427
0.93%
0.05%
0.93%
Apr 2025
Axis Small Cap Fund Direct-Growth
2525796
1.91%
0.03%
0.17%
Apr 2025
Bandhan BSE Healthcare Index Fund Direct-Growth
960
0.94%
0.02%
0.07%
Apr 2025
Union Active Momentum Fund Direct-Growth
50339
2.11%
0.02%
2.11%
Apr 2025
DSP Multi Asset Allocation Fund Direct - Growth
119702
0.71%
-0.02%
0.05%
Apr 2025

About Narayana Hrudayalaya

Narayana Hrudayalaya Limited is a healthcare company founded in 2000 by Dr. Devi Prasad Shetty. It operates a network of 23 multi-specialty and super-specialty hospitals, including 7 heart centers, across 18 locations in India and 1 in the Cayman Islands. The company provides a wide range of medical services, including cardiac sciences, oncology, gastroenterology, neurology, and pediatrics. Narayana Hrudayalaya has expanded its operations through acquisitions and partnerships, such as establishing a hospital in Nairobi, Kenya. The company is known for offering affordable quality care and has received NABH accreditation for multiple units. It became publicly listed on the BSE and NSE in January 2016.
Listing Date
06 Jan, 2016(9 Years, 23 days)
Chairperson NameDEVI PRASAD SHETTY